The article discusses how FutureHouse—a research lab co-founded by MIT alumnus Sam Rodriques—has developed an AI platform to automate critical steps in scientific discovery, such as literature review, data analysis, and experiment design. Drawing on concerns about slowing scientific productivity, FutureHouse leverages specialized AI agents (like Crow, Owl, Falcon, Phoenix, and Finch) to assist scientists in overcoming research bottlenecks. These agents help researchers quickly retrieve and synthesize information, design experiments, and generate and test hypotheses. The platform, available to anyone, has already facilitated progress in diseases like macular degeneration, polycystic ovary syndrome, and Parkinson’s disease. The founders believe integrating these agents with advanced computational and language models will be key to accelerating science in the future.





























